These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7376162)

  • 1. [Circulatory effects of opiate antagonists. Naloxone in circulatory shock].
    Maurset A
    Tidsskr Nor Laegeforen; 1980 Feb; 100(4):237. PubMed ID: 7376162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naloxone in the treatment of shock].
    Jastrzebski J; Wyszyński C; Złotorowicz M
    Pol Tyg Lek; 1984 Oct; 39(43):1409-12. PubMed ID: 6514614
    [No Abstract]   [Full Text] [Related]  

  • 3. [Naloxone and cardiogenic shock].
    Unzueta Merino MC; Bonnin O; Cabrera Ruiz JC; Villar Landeira JM
    Rev Esp Anestesiol Reanim; 1987; 34(6):446-9. PubMed ID: 3423375
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone--opiate antagonist.
    Drug Ther Bull; 1981 Oct; 19(21):83-4. PubMed ID: 7285806
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone in shock and toxic coma.
    Chen HL
    Am J Emerg Med; 1984 Sep; 2(5):444-52. PubMed ID: 6394006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs approved for opiate dependence.
    FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
    [No Abstract]   [Full Text] [Related]  

  • 7. Opiate antagonists in shock.
    Hinds CJ
    Br J Hosp Med; 1985 Oct; 34(4):233-4. PubMed ID: 4092134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone in shock.
    Lancet; 1980 Dec 20-27; 2(8208-8209):1360. PubMed ID: 6109169
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of undesirable effects during the use of opiate antagonists].
    Rust M
    Klin Anasthesiol Intensivther; 1993; 42():108-16. PubMed ID: 8450619
    [No Abstract]   [Full Text] [Related]  

  • 11. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 12. Naloxone for intractable pruritus?
    Zuckerman E; Schar M; Korula J
    Am J Gastroenterol; 1997 Jan; 92(1):183-4. PubMed ID: 8995978
    [No Abstract]   [Full Text] [Related]  

  • 13. Caution with naloxone use in asthmatic patients.
    Allegretti PJ; Bzdusek JS; Leonard J
    Am J Emerg Med; 2006 Jul; 24(4):515-6. PubMed ID: 16787825
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of opiate antagonists in the treatment of shock. Description of a case of shock treated with naloxone].
    Grzeszczak W
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1631-2. PubMed ID: 6679088
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe withdrawal from short-term transdermal fentanyl after naloxone for uremic pruritus.
    Finsterer J; Keller H; Arias I; Zuntner G
    J Pain Symptom Manage; 2004 May; 27(5):387-8. PubMed ID: 15120761
    [No Abstract]   [Full Text] [Related]  

  • 19. Hazards of antagonizing narcotic sedation with naloxone.
    Neal JM; Owens BD
    Ann Emerg Med; 1993 Jan; 22(1):145-6. PubMed ID: 8481202
    [No Abstract]   [Full Text] [Related]  

  • 20. The pruritus of cholestasis is relieved by an opiate antagonist: is this pruritus a centrally mediated phenomenon?
    Heathcote J
    Hepatology; 1996 May; 23(5):1280-2. PubMed ID: 8621166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.